Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Trastuzumab 440 mg powder for solution for injection vial |
Is a |
Trastuzumab 150 mg powder for solution for injection vial |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Trastuzumab 440 mg powder for solution for injection vial |
Is a |
Product containing trastuzumab (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Trastuzumab 440 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Trastuzumab 440 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Biological agent |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Trastuzumab 440 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Trastuzumab |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Trastuzumab 440 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Monoclonal antibody |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Trastuzumab 440 mg powder for solution for injection vial |
Has manufactured dose form |
Injection (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Trastuzumab 440 mg powder for solution for injection vial |
Is a |
Product manufactured as parenteral dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Trastuzumab 440 mg powder for solution for injection vial |
Has manufactured dose form |
Powder for solution for injection |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Trastuzumab 440 mg powder for solution for injection vial |
Is a |
Product containing trastuzumab in parenteral dose form (medicinal product form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Trastuzumab 440 mg powder for solution for injection vial |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Trastuzumab 440 mg powder for solution for injection vial |
Has basis of strength substance (attribute) |
Trastuzumab |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Trastuzumab 440 mg powder for solution for injection vial |
Has presentation strength numerator value |
440 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Trastuzumab 440 mg powder for solution for injection vial |
Has precise active ingredient |
Trastuzumab |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Trastuzumab 440 mg powder for solution for injection vial |
Is a |
Trastuzumab only product in parenteral dose form |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Trastuzumab 440 mg powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
Vial (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Trastuzumab 440 mg powder for solution for injection vial |
Has presentation strength numerator unit (attribute) |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Trastuzumab 440 mg powder for solution for injection vial |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Trastuzumab 440 mg powder for solution for injection vial |
Count of base of active ingredient |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Trastuzumab 440 mg powder for solution for injection vial |
Has unit of presentation |
Vial (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Trastuzumab 440 mg powder for solution for injection vial |
Plays role |
Antineoplastic therapeutic role |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|